
Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies
Keywords: آگونیست CB2; Pyridazine-3-carboxamides; CB2 agonist; Structure-activity relationships; Molecular docking; logP;